Tofacitinib in Ulcerative Colitis - Second-Line Therapy, First-Rate Results

Dig Dis Sci. 2024 Sep;69(9):3116-3118. doi: 10.1007/s10620-024-08589-1. Epub 2024 Aug 22.

Author

Sidharth Harindranath¹

Affiliation

¹ Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Multi-Storey Building, 9thFloor, Parel, Mumbai, Maharashtra, 400012, India. [email protected].

PMID: 39172324
DOI: 10.1007/s10620-024-08589-1

No abstract available

Publication types

Letter
Editorial

MeSH terms

Colitis, Ulcerative* / drug therapy
Humans
Piperidines* / therapeutic use
Protein Kinase Inhibitors / therapeutic use
Pyrimidines* / therapeutic use
Pyrroles* / therapeutic use
Treatment Outcome

Substances

tofacitinib
Piperidines
Pyrimidines
Pyrroles
Protein Kinase Inhibitors